Beta Drugs (NSE:BETA) Price-to-Operating-Cash-Flow : 36.99 (As of Jun. 05, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Price-to-Operating-Cash-Flow?

As of today (2024-06-05), Beta Drugs's share price is ₹1190.15. Beta Drugs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹32.17. Hence, Beta Drugs's Price-to-Operating-Cash-Flow Ratio for today is 36.99.

The historical rank and industry rank for Beta Drugs's Price-to-Operating-Cash-Flow or its related term are showing as below:

NSE:BETA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.24 Med: 24.99 Max: 921.32
Current: 37.37

During the past 12 years, Beta Drugs's highest Price-to-Operating-Cash-Flow Ratio was 921.32. The lowest was 3.24. And the median was 24.99.

NSE:BETA's Price-to-Operating-Cash-Flow is ranked worse than
80.65% of 682 companies
in the Drug Manufacturers industry
Industry Median: 16.105 vs NSE:BETA: 37.37

Beta Drugs's Cash Flow from Operations per share for the six months ended in Mar. 2024 was ₹18.53. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹32.17.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Beta Drugs was 32.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 18.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 143.40% per year.

During the past 12 years, Beta Drugs's highest 3-Year average Operating Cash Flow per Share Growth Rate was 520.50% per year. The lowest was -0.70% per year. And the median was 40.60% per year.

Beta Drugs Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Beta Drugs's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Price-to-Operating-Cash-Flow Chart

Beta Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

4.57

6.20

18.35

25.78

38.35

Beta Drugs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial														18.35	-	25.78	-	38.35

Competitive Comparison of Beta Drugs's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Price-to-Operating-Cash-Flow falls into.

Beta Drugs Price-to-Operating-Cash-Flow Calculation

Beta Drugs's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1190.15	/	32.174
	=	36.99

Beta Drugs's Share Price of today is ₹1190.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beta Drugs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹32.17.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Beta Drugs Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Beta Drugs (NSE:BETA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Price-to-Operating-Cash-Flow

Traded in Other Exchanges

N/A

Address

SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114

Website

https://www.betadrugslimited.com

Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports it to other countries of which key revenue is derived from the sales made in India.

Beta Drugs (NSE:BETA) Headlines

No Headlines